Deal facts
- Buyer
- Altaris, LLC
- Target
- Clarivate Plc
- Deal value
- USD 600,000,000
- Announced
- 6 July 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash, loan-note, deferred
Sources
Altaris, LLC has agreed to acquire Clarivate Plc in a completed asset sale. The transaction, announced on 6 July 2026, was valued at 600 million US dollars as a headline offer. Both the buyer and the target are based in the United States, operating within the healthcare sector. The deal structure involved a combination of cash, a loan note, and deferred consideration. This arrangement facilitated the transfer of specific assets rather than the entire corporate entity, allowing for a tailored acquisition approach. The completion of the transaction occurred on 6 October 2026, marking the finalisation of the agreement between the two US-based entities.
The process concluded with the successful closing of the deal, ensuring that all contractual obligations were met. The inclusion of deferred payment terms suggests a structured approach to the financial settlement, aligning with the specific requirements of the asset sale. With the transaction now completed, the assets have been formally transferred to Altaris, LLC. This outcome reflects the successful execution of the agreed terms without any reported delays or regulatory hurdles. The final status confirms that the deal has been fully executed, providing clarity on the current ownership of the acquired healthcare assets.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Altaris, LLC completes acquisition of Clarivate Plc
Item 2.01. Completion of Acquisition or Disposition of Assets. On October 6, 2026, Clarivate Plc (“ Clarivate ”) completed the previously announced sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC (“ Buyer ”) pursuant to the Stock and Asset Purchase Agreement (the “ Purchase Agreement ”), dated as of July 3, 2026, between certain subsidiaries of Clarivate and Buyer
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Larry King
Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Bot…
- Buyer
- Silo Pharma, Inc.
- Target
- Larry King
- Deal value
- Not disclosed
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Norsight Consulting Inc.
Silo Pharma, Inc. has agreed to acquire assets from Norsight Consulting Inc. in a transaction announced on 2 October 2026. Both companies are based in the United States…
- Buyer
- Silo Pharma, Inc.
- Target
- Norsight Consulting Inc.
- Deal value
- Not disclosed
- Deal type
- asset sale
JOINT Corp to acquire The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
JOINT Corp has agreed to acquire a portfolio of five Texas-based entities from The Joint franchise network. The transaction, announced and completed on 1 October 2026, i…
- Buyer
- JOINT Corp
- Target
- The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
- Deal value
- USD 8,000,000
- Deal type
- asset sale
Element Biosystems, LLC to acquire Standard BioTools Inc.
Element Biosystems, LLC has agreed to acquire Standard BioTools Inc. in a cash asset sale. The transaction was announced on 30 September 2026 and is valued at five milli…
- Buyer
- Element Biosystems, LLC
- Target
- Standard BioTools Inc.
- Deal value
- USD 5,500,000
- Deal type
- asset sale
Buyer history
Altaris, LLC
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive